(S027) The Emotional Intelligence of Chairs of Academic Radiation Oncology Programs

Publication
Article
OncologyOncology Vol 30 No 4_Suppl_1
Volume 30
Issue 4_Suppl_1

Academic radiation oncology chairs have high emotional Intelligence, and increased emotional Intelligence correlates significantly with decreased rates of self-reported burnout. In the future, emotional Intelligence scores may be of increasing importance when it comes to recruitment and retention of academic medical leadership.

Emma B. Holliday, MD, James A. Bonner, MD, Silvia C. Formenti, MD, Stephen M. Hahn, MD, Shalom Kalnicki, MD, Fei-Fei Liu, MD, Benjamin Movsas, MD, Clifton D. Fuller, MD, PhD, Charles R. Thomas, Jr, MD; UT MD Anderson Cancer Center; Department of Radiation Oncology, University of Alabama; Department of Radiation Oncology, Weill Cornell Medical College; Department of Radiation Oncology, Albert Einstein College of Medicine; Department of Radiation Oncology, Princess Margaret Cancer Center; Department of Radiation Oncology, Henry Ford Hospital; Department of Radiation Medicine, Knight Cancer Institute, Oregon Health and Science University

BACKGROUND: Emotional Intelligence (EI) has attracted recent attention as a desirable trait for physicians. The Accreditation Council for Graduate Medical Education has incorporated aspects of EI into its core competencies by which resident physicians are evaluated. There is likewise emerging interest in the relationship of EI to retention, promotion, and academic productivity; however, to date, there has been no formal evaluation of EI among current department chairs. Therefore, our objectives were to assess the EI of current chairs of academic radiation oncology departments and correlate EI with self-reported assessment of burnout.

METHODS: Ninety-five current chairs of academic radiation oncology departments were invited to participate in an institutional review board (IRB)-approved survey containing questions regarding general demographics and chair experience, the Trait Emotional Intelligence Questionnaire Short Form (TEIQue-SF), and the abbreviated Maslach Burnout Inventory (a-MBI). TEIQue-SF scores were evaluated for correlation with respondent demographics and self-reported burnout scores on the a-MBI.

RESULTS: Sixty chairs responded to the survey, for a response rate of 63.2%. Nine respondents (15%) were female, and the remaining 51 (85%) were male. The median (interquartile range [IQR]) TEIQue-SF for the responding cohort was 172 (155–182) out of a maximum possible score of 210. The a-MBI Emotional Exhaustion and Depersonalization subscores were low for the responding cohort with a median (IQR) of 4 (2.25–6.75) and 1 (0–2.75) out of a maximum possible of 18 and 30, respectively. Higher TEIQue-SF global scores were significantly correlated with decreased burnout on all a-MBI subscores.

CONCLUSIONS: Academic radiation oncology chairs have high EI, and increased EI correlates significantly with decreased rates of self-reported burnout. In the future, EI scores may be of increasing importance when it comes to recruitment and retention of academic medical leadership.

Proceedings of the 98th Annual Meeting of the American Radium Society - americanradiumsociety.org

Articles in this issue

(S002) A 15-Year Review of Radiation Therapy for Keloids at Two Institutions
(S003) Single-Fraction Radiation Therapy for the Treatment of Multiple Myeloma Bony Metastases Provides Pain Control and Decreases Time to Chemotherapy
(S001) Prognostic Value of Pretreatment Serum Inflammatory Markers in Patients Receiving Radiation Therapy for Oropharyngeal Cancer
(S004) Trend in Second Malignancy Risk for Head and Neck Cancer With Increased Utilization of IMRT: Analysis of SEER Database
(S005) Comparison of Legal Needs of a Group of Patients With Cancer: Economic and Geographic Factors
(S006) Mission Improvement: Lessons From Initiating a Resident-Led Quality Improvement Project on Smoking Cessation at a County Hospital
(S007) Results of a Phase II Trial Using Cetuximab Plus Docetaxel With Low-Dose Fractionated Radiation for Recurrent Unresectable Locally Advanced Head and Neck Carcinoma
(S008) The Effect of Simulation and Treatment Delays for Patients With Oropharyngeal Cancer Receiving Definitive Radiation Therapy in the Era of Risk Stratification Using Smoking and Human Papilloma Virus Status
(S009) Intensity-Modulated Radiation Therapy With Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: A Report on Three-Year Toxicity
(S011) Comparative Study Between Ileal Conduit and Indiana Pouch After Cystectomy for Patients With Carcinoma of Urinary Bladder
(S010) Computed Tomography–Assessed Measures of Bone Mineral Density and Muscle Mass as Predictors of Survival in Men With Prostate Cancer
(S012) Quantitative Imaging to Evaluate the Malignant Potential of Pancreatic Cysts
(S013) Spine Stereotactic Radiosurgery With Concurrent Tyrosine Kinase Inhibitors for Metastatic Renal Cell Carcinoma
(S014) The Impact of Radiation Therapy on Survival in Surgically Resected, High-Risk Patients With Ampullary Adenocarcinoma: A Population-Based Analysis
(S016) The Impact of Stereotactic Body Radiation Therapy on Overall Survival in Patients With Locally Advanced Pancreatic Cancer
Recent Videos
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
Although accuracy remains a focus in whole-body MRI testing in patients with Li-Fraumeni syndrome, comfortable testing experiences may ease anxiety.
Subsequent testing among patients in a prospective study may affirm the ability of cfDNA sequencing to detect cancers in those with Li-Fraumeni syndrome.
cfDNA sequencing may allow for more accessible, frequent, and sensitive testing compared with standard surveillance in Li-Fraumeni syndrome.
STX-478 showed efficacy in patients with advanced solid tumors regardless of whether they had kinase domain or helical PI3K mutations.
STX-478 may avoid adverse effects associated with prior PI3K inhibitors that lack selectivity for the mutated protein vs the wild-type protein.
Phase 1 data may show the possibility of rationally designing agents that can preferentially target PI3K mutations in solid tumors.
Funding a clinical trial to further assess liquid biopsy in patients with Li-Fraumeni syndrome may help with detecting cancers early across the board.
Michael J. Hall, MD, MS, FASCO, discusses the need to reduce barriers to care for those with Li-Fraumeni syndrome, including those who live in rural areas.
Related Content